Browse Category

Company News News 14 November 2025 - 16 November 2025

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited heads into Monday’s open with investors still digesting a tough few months: a surprise guidance downgrade and delayed vaccines demerger at the late‑October AGM, followed by a steady drumbeat of daily buy‑back notices last week. Below is a
Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Warner Bros. Discovery (WBD) Stock Climbs as Paramount, Comcast and Netflix Line Up Bids in High‑Stakes Auction – November 14, 2025

Warner Bros. Discovery, Inc. (NASDAQ: WBD) moved back into the spotlight on Friday, November 14, 2025, as a potential sale of all or part of the media giant appeared to crystallize into a three‑way contest between Paramount Skydance, Comcast and
Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor, Inc. (NASDAQ: TRIP) returned to investors’ good graces on Friday after Mizuho upgraded the online travel company and lifted its price target, signaling Wall Street is starting to warm to an aggressive restructuring that includes layoffs, a Viator merger
TSS Inc. (TSSI) Stock Plunges Over 40% After Q3 2025 Earnings – AI Pivot, New Dell Veteran Director and What’s Next for 2026

TSS Inc. (TSSI) Stock Plunges Over 40% After Q3 2025 Earnings – AI Pivot, New Dell Veteran Director and What’s Next for 2026

TSS, Inc. (NASDAQ: TSSI), the AI‑focused data center systems integrator, is at the center of a dramatic market move today. Shares are trading in the high single digits this afternoon, down a little over 40% from yesterday’s close around $15.25,
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer Stock (PFE) Before the Bell on November 14, 2025: Metsera Deal Closes, BioNTech Stake Cut and Guidance Raised

As Wall Street heads into Friday’s session, Pfizer stock is trading slightly lower in premarket action while investors digest a trio of big developments: the completed acquisition of obesity‑drug developer Metsera, a sharp reduction in Pfizer’s stake in BioNTech, and
1 29 30 31 32 33 41
Go toTop